PT1467737E - Composicao farmaceutica orodispersivel de piribedil - Google Patents

Composicao farmaceutica orodispersivel de piribedil

Info

Publication number: PT1467737E
Authority: PT; Portugal
Prior art keywords: orodispersivel; pyribedil; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2002-01-21

Application number

PT03709892T

Other languages

English (en)

Inventor

Patrick Wuthrich

Rolland Herve

Julien Marc

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-21

Filing date

2003-01-21

Publication date

2006-08-31

2003-01-21 Application filed by Servier Lab filed Critical Servier Lab

2006-08-31 Publication of PT1467737E publication Critical patent/PT1467737E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Psychology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

PT03709892T 2002-01-21 2003-01-21 Composicao farmaceutica orodispersivel de piribedil PT1467737E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0200671A FR2834894B1 (fr)	2002-01-21	2002-01-21	Composition pharmaceutique orodispersible de piribedil

Publications (1)

Publication Number	Publication Date
PT1467737E true PT1467737E (pt)	2006-08-31

Family

ID=27589523

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT03709892T PT1467737E (pt)	2002-01-21	2003-01-21	Composicao farmaceutica orodispersivel de piribedil

Country Status (27)

Country	Link
US (1)	US20050085485A1 (pt)
EP (1)	EP1467737B1 (pt)
JP (1)	JP4500051B2 (pt)
KR (1)	KR100588223B1 (pt)
CN (1)	CN100352440C (pt)
AR (1)	AR038194A1 (pt)
AT (1)	ATE327758T1 (pt)
AU (1)	AU2003214326B2 (pt)
BR (1)	BR0306869A (pt)
CA (1)	CA2473152C (pt)
CY (1)	CY1105414T1 (pt)
DE (1)	DE60305642T2 (pt)
DK (1)	DK1467737T3 (pt)
EA (1)	EA007286B1 (pt)
ES (1)	ES2263959T3 (pt)
FR (1)	FR2834894B1 (pt)
GE (1)	GEP20063819B (pt)
HK (1)	HK1081110A1 (pt)
MA (1)	MA27098A1 (pt)
MX (1)	MXPA04007035A (pt)
NO (1)	NO20043474L (pt)
NZ (1)	NZ533820A (pt)
PL (1)	PL204939B1 (pt)
PT (1)	PT1467737E (pt)
UA (1)	UA78277C2 (pt)
WO (1)	WO2003061661A1 (pt)
ZA (1)	ZA200405008B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9884082B2 (en)	2008-11-13	2018-02-06	David A. Hamlin	Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9597278B2 (en)	2008-11-13	2017-03-21	David A. Hamlin	Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE575343A (pt) *	1955-09-09
FR2355502A1 (fr) *	1976-06-23	1978-01-20	Roussel Uclaf	Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) *	1980-12-15	1984-10-10	Gergely Gerhard	Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) *	1985-02-16	1986-08-21	Basf Ag, 6700 Ludwigshafen	Direkttablettierhilfsmittel
DE3506276C1 (de) *	1985-02-22	1986-04-24	Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring	Direkttablettiermittel
JP3253127B2 (ja) *	1991-06-07	2002-02-04	帝國製薬株式会社	生理活性ポリペプチド含有製剤
FR2710265B1 (fr) *	1993-09-22	1995-10-20	Adir	Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
PL187160B1 (pl) *	1994-01-31	2004-05-31	Yamanouchi Pharma Co Ltd	Sposób wytwarzania rozpuszczalnej wewnątrzustnie formowanej tłocznie wypraski
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions
GB9700878D0 (en) *	1997-01-17	1997-03-05	Scherer Ltd R P	Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) *	1997-04-16	2000-02-15	Cima Labs Inc.	Rapidly dissolving robust dosage form
JP2001526662A (ja) *	1997-05-09	2001-12-18	フェロンパテントリミテッド	舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
JP2983973B1 (ja) *	1998-10-13	1999-11-29	大正薬品工業株式会社	口腔内速崩壊性固形製剤
JP2000273039A (ja) *	1999-01-20	2000-10-03	Taisho Pharmaceut Co Ltd	口腔内崩壊性組成物
JP2001058944A (ja) *	1999-06-18	2001-03-06	Takeda Chem Ind Ltd	速崩壊性固形製剤
AU2001273496A1 (en) *	2000-07-24	2002-02-05	Boehringer Ingelheim Pharmaceuticals Inc.	Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
ATE371439T1 (de) *	2000-07-27	2007-09-15	Roquette Freres	Granulat bestehend aus stärke und laktose
UA80393C2 (uk) *	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US7118765B2 (en) *	2001-12-17	2006-10-10	Spi Pharma, Inc.	Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) *	2002-01-18	2004-04-02	Roquette Freres	Forme pharmaceutique solide orodispersible

2002
- 2002-01-21 FR FR0200671A patent/FR2834894B1/fr not_active Expired - Fee Related
2003
- 2003-01-21 CA CA2473152A patent/CA2473152C/fr not_active Expired - Fee Related
- 2003-01-21 DE DE60305642T patent/DE60305642T2/de not_active Expired - Lifetime
- 2003-01-21 CN CNB038025256A patent/CN100352440C/zh not_active Expired - Fee Related
- 2003-01-21 PT PT03709892T patent/PT1467737E/pt unknown
- 2003-01-21 BR BR0306869-2A patent/BR0306869A/pt not_active IP Right Cessation
- 2003-01-21 NZ NZ533820A patent/NZ533820A/en not_active IP Right Cessation
- 2003-01-21 DK DK03709892T patent/DK1467737T3/da active
- 2003-01-21 EP EP03709892A patent/EP1467737B1/fr not_active Expired - Lifetime
- 2003-01-21 AR ARP030100162A patent/AR038194A1/es not_active Application Discontinuation
- 2003-01-21 ES ES03709892T patent/ES2263959T3/es not_active Expired - Lifetime
- 2003-01-21 US US10/502,078 patent/US20050085485A1/en not_active Abandoned
- 2003-01-21 GE GE5626A patent/GEP20063819B/en unknown
- 2003-01-21 EA EA200400885A patent/EA007286B1/ru not_active IP Right Cessation
- 2003-01-21 PL PL370168A patent/PL204939B1/pl not_active IP Right Cessation
- 2003-01-21 AT AT03709892T patent/ATE327758T1/de active
- 2003-01-21 UA UA20040806962A patent/UA78277C2/uk unknown
- 2003-01-21 WO PCT/FR2003/000179 patent/WO2003061661A1/fr active IP Right Grant
- 2003-01-21 MX MXPA04007035A patent/MXPA04007035A/es active IP Right Grant
- 2003-01-21 JP JP2003561605A patent/JP4500051B2/ja not_active Expired - Fee Related
- 2003-01-21 KR KR1020047011236A patent/KR100588223B1/ko not_active IP Right Cessation
- 2003-01-21 AU AU2003214326A patent/AU2003214326B2/en not_active Ceased
2004
- 2004-06-24 ZA ZA2004/05008A patent/ZA200405008B/en unknown
- 2004-07-06 MA MA27766A patent/MA27098A1/fr unknown
- 2004-08-20 NO NO20043474A patent/NO20043474L/no not_active Application Discontinuation
2006
- 2006-01-26 HK HK06101212A patent/HK1081110A1/xx not_active IP Right Cessation
- 2006-06-30 CY CY20061100899T patent/CY1105414T1/el unknown

Also Published As

Publication number	Publication date
DE60305642T2 (de)	2007-05-16
CN1688313A (zh)	2005-10-26
WO2003061661A1 (fr)	2003-07-31
AR038194A1 (es)	2005-01-05
CA2473152A1 (fr)	2003-07-31
NZ533820A (en)	2005-08-26
CN100352440C (zh)	2007-12-05
DE60305642D1 (de)	2006-07-06
CY1105414T1 (el)	2010-04-28
KR20040075098A (ko)	2004-08-26
MA27098A1 (fr)	2004-12-20
CA2473152C (fr)	2010-08-31
GEP20063819B (en)	2006-05-10
KR100588223B1 (ko)	2006-06-12
ZA200405008B (en)	2005-08-31
PL204939B1 (pl)	2010-02-26
JP2005529068A (ja)	2005-09-29
US20050085485A1 (en)	2005-04-21
EP1467737B1 (fr)	2006-05-31
FR2834894B1 (fr)	2004-02-27
JP4500051B2 (ja)	2010-07-14
BR0306869A (pt)	2004-11-03
AU2003214326B2 (en)	2007-08-02
FR2834894A1 (fr)	2003-07-25
EA200400885A1 (ru)	2004-12-30
NO20043474L (no)	2004-08-20
HK1081110A1 (en)	2006-05-12
MXPA04007035A (es)	2004-10-11
ES2263959T3 (es)	2006-12-16
PL370168A1 (en)	2005-05-16
UA78277C2 (en)	2007-03-15
EP1467737A1 (fr)	2004-10-20
EA007286B1 (ru)	2006-08-25
DK1467737T3 (da)	2006-09-18
ATE327758T1 (de)	2006-06-15

Publication	Publication Date	Title
ATE380544T1 (de)	2007-12-15	Umhüllte feste darreichungsform
CY2017048I2 (el)	2018-09-05	Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
CY2018005I1 (el)	2018-06-27	Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
IS7714A (is)	2005-02-24	Lyfjasamsetningar úr módafíníl
CY2015003I2 (el)	2015-12-09	Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
PT1467724E (pt)	2006-08-31	Composicao farmaceutica orodispersavel de agomelatina
FI20011478L (fi)	2003-01-06	Farmaseuttinen koostumus
EP1506786A4 (en)	2009-07-29	MEDICAL GHRELIN CONTAINING COMPOSITIONS
FR2842416B1 (fr)	2004-12-17	Composition cosmetique
FR2842417B1 (fr)	2005-01-21	Composition cosmetique
DK1425019T3 (da)	2008-02-04	Farmaceutisk sammensætning omfattende et androgen
IS7051A (is)	2003-11-26	Lyfjasamsetningar
ATE309789T1 (de)	2005-12-15	Darreichungsform von ibuprofen-natrium
NO20052952D0 (no)	2005-06-16	Farmasoytisk sammensetning som innbefatter mikropartikler
PT1558263E (pt)	2006-10-31	Composicao farmaceutica de libertacao prolongada
ITMI20021684A1 (it)	2004-01-29	Composizione farmaceutica di peptide nasale
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
IS2707B (is)	2011-01-15	Nýjar lyfjasamsetningar úr módafíníli
NO20043576L (no)	2004-12-22	Pharmaceutical formulation comprising melatonin
HK1094153A1 (en)	2007-03-23	Nasal pharmaceutical composition of piribedil
PT1467737E (pt)	2006-08-31	Composicao farmaceutica orodispersivel de piribedil
NO20044164L (no)	2004-09-30	Farmasoytiske sammensetninger
DE112004001429D2 (de)	2006-04-13	Pharmazeutischer Wirkstoff
DOP2002000508A (es)	2003-06-15	Composición farmaceutica